Applicant, as named in the Orange Book

Vanda Pharms Inc

Next listed expiry: Fanapt on 28 Dec 2031. 6 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Fanapt · 7 strengths iloperidone	iloperidone	022192	28 Dec 2031	patent, carve-out possible
Nereus tradipitant	tradipitant	220152	9 Aug 2036	patent, carve-out possible
Hetlioz tasimelteon	tasimelteon	205677	21 Feb 2041	patent, carve-out possible
Hetlioz Lq tasimelteon	tasimelteon	214517	21 Feb 2041	patent, carve-out possible
Bysanti · 7 strengths milsaperidone	milsaperidone	220358	31 May 2044	patent, carve-out possible
Ponvory · 2 strengths ponesimod	ponesimod	213498	24 Dec 2044	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.